메뉴 건너뛰기




Volumn 20, Issue 24, 2012, Pages 7175-7183

N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα)

Author keywords

AKT phosphorylation; Apoptosis; Colon cancer; PI3K; Selectivity

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; N (2 FLUOROPHENYL) 8 FLUORO 4 HYDROXY 2 QUINOLONE 3 CARBOXAMIDE; N (3 FLUOROPHENYL) 7 FLUORO 4 HYDROXY 2 QUINOLONE 3 CARBOXAMIDE; N (4 FLUOROPHENYL) 6 FLUORO 4 HYDROXY 2 QUINOLONE 3 CARBOXAMIDE; N (4 METHOXYPHENYL) 4 HYDROXY 6 METHOXY 2 QUINOLONE 3 CARBOXAMIDE; N 4 TOLYL 4 HYDROXY 6 METHYL 2 QUINOLONE 3 CARBOXAMIDE; N BENZYL 2 HYDROXYQUINOLINE 3 CARBOXAMIDE; N BENZYL QUINOLINE 3 CARBOXAMIDE; N PHENYL 4 HYDROXY 1 METHYL 2 QUINOLONE 3 CARBOXAMIDE; N PHENYL 4 HYDROXY 2 QUINOLONE 3 CARBOXAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; UNCLASSIFIED DRUG;

EID: 84870053134     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2012.09.059     Document Type: Article
Times cited : (33)

References (49)
  • 47
    • 84871476401 scopus 로고    scopus 로고
    • Molecular Operating Environment (moe) Chemical Computing Group Inc. Montreal, QC, Canada 2009
    • The Molecular Operating Environment (MOE) 2009 Chemical Computing Group Inc. Montreal, QC, Canada


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.